Form 4: Legence Director Buys Shares, Receives RSU Award

Legence Corp. Director Terrence Keenen acquired 8,928 shares through an IPO directed share program and received an award of 5,357 Restricted Stock Units.

Summary

• Terrence Keenen, a Director of Legence Corp. (LGN), reported two transactions on September 15, 2025.
• Keenen purchased 8,928 shares of Class A Common Stock at a price of $28 per share through a directed share program in connection with the company's initial public offering.
• Keenen also received an award of 5,357 Restricted Stock Units (RSUs), which entitle him to one share of Class A common stock per unit upon vesting, with a transaction price of $0.00.
• Following these transactions, Keenen beneficially owns a total of 14,285 shares of Class A Common Stock.
• The RSUs will fully vest on the earlier of the first anniversary of the award date or the day immediately preceding the Issuer's 2026 annual stockholder meeting, subject to continued service.

Sentiment

Score: 7

Explanation: The sentiment is positive. A director's purchase of shares, even through a directed program, signals confidence. The RSU award further aligns management interests with shareholders, which is generally viewed favorably by investors.

Positives

• A Director's purchase of 8,928 shares at $28 per share through a directed share program indicates confidence in the company's valuation and future prospects.
• The award of 5,357 Restricted Stock Units (RSUs) aligns the Director's interests with those of shareholders, as vesting is contingent on continued service and future performance.

Risks

• The vesting of the 5,357 Restricted Stock Units is subject to Terrence Keenen's continued service through the vesting date, meaning the shares are not immediately owned outright.

Future Outlook

The 5,357 Restricted Stock Units awarded to Director Terrence Keenen are scheduled to vest on the earlier of the first anniversary of the award date or the day immediately preceding the Issuer's 2026 annual stockholder meeting, contingent on his continued service.

Industry Context

Form 4 filings are standard disclosures for insider transactions, providing transparency into management and director ownership changes. Directed share programs are common in initial public offerings (IPOs) to allow certain individuals, including directors, to purchase shares at the IPO price, fostering early alignment.

Related Party Transactions

• Director Terrence Keenen's purchase of 8,928 shares through a directed share program in connection with the company's IPO constitutes a related party transaction.
• The award of 5,357 Restricted Stock Units to Director Terrence Keenen is also a related party transaction, representing equity compensation.

Stakeholder Impact

• Shareholders: Increased confidence due to director's investment and alignment of interests through equity awards.
• Employees: No direct impact mentioned, but general positive sentiment from director confidence could indirectly benefit morale.

Next Steps

• Vesting of 5,357 Restricted Stock Units for Director Terrence Keenen on the earlier of the first anniversary of the award date or the day preceding the 2026 annual stockholder meeting.

Key Dates

Recommendation

While a director's share purchase and RSU award are positive signals of confidence and alignment, this Form 4 filing alone does not provide sufficient new information to warrant a 'buy' or 'sell' recommendation. It confirms expected insider activity around an IPO. Investors should 'hold' and monitor broader company performance and market conditions.

Keywords

Legence Corp, LGN, Form 4, Insider Transaction, Director, Share Purchase, Restricted Stock Units, RSU, IPO, Equity Award, Beneficial Ownership